Cubist Is Latest Heptares Collaborator On GPCR-Targeted Drugs
This article was originally published in The Pink Sheet Daily
Executive Summary
U.S. acute hospital care specialist Cubist has become the sixth major pharma company to collaborate with U.K.-based Heptares on finding novel therapeutics that interact with G-protein coupled receptors.